Elia Gigante

567 total citations
23 papers, 356 citations indexed

About

Elia Gigante is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Elia Gigante has authored 23 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hepatology, 12 papers in Epidemiology and 7 papers in Surgery. Recurrent topics in Elia Gigante's work include Liver Disease Diagnosis and Treatment (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers). Elia Gigante is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers). Elia Gigante collaborates with scholars based in France, Italy and United States. Elia Gigante's co-authors include Tatiana Kisseleva, David A. Brenner, Massimo Marignani, Paola Begini, Valérie Paradis, Olivier Soubrane, Maxime Ronot, Adriano Pellicelli, Giulio Antonelli and François Cauchy and has published in prestigious journals such as Scientific Reports, Journal of Hepatology and World Journal of Gastroenterology.

In The Last Decade

Elia Gigante

22 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elia Gigante France 10 160 126 121 109 87 23 356
Yoshifumi Suga Japan 8 255 1.6× 64 0.5× 229 1.9× 149 1.4× 63 0.7× 16 412
Tomonari Okudaira Japan 10 263 1.6× 67 0.5× 238 2.0× 159 1.5× 64 0.7× 20 442
Takuya Kuwashiro Japan 11 214 1.3× 58 0.5× 289 2.4× 174 1.6× 49 0.6× 22 485
Ayumu Goto Japan 12 68 0.4× 216 1.7× 62 0.5× 87 0.8× 206 2.4× 44 484
Yifei Tan China 11 151 0.9× 85 0.7× 130 1.1× 34 0.3× 88 1.0× 25 336
Alessandro Giani Italy 14 129 0.8× 221 1.8× 68 0.6× 89 0.8× 230 2.6× 44 442
Soichi Iritani Japan 8 115 0.7× 74 0.6× 99 0.8× 197 1.8× 63 0.7× 15 324
Fatih Saygılı Türkiye 9 24 0.1× 123 1.0× 43 0.4× 105 1.0× 104 1.2× 18 286
Shirin Feshtali Netherlands 10 119 0.7× 82 0.7× 107 0.9× 149 1.4× 148 1.7× 24 357

Countries citing papers authored by Elia Gigante

Since Specialization
Citations

This map shows the geographic impact of Elia Gigante's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elia Gigante with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elia Gigante more than expected).

Fields of papers citing papers by Elia Gigante

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elia Gigante. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elia Gigante. The network helps show where Elia Gigante may publish in the future.

Co-authorship network of co-authors of Elia Gigante

This figure shows the co-authorship network connecting the top 25 collaborators of Elia Gigante. A scholar is included among the top collaborators of Elia Gigante based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elia Gigante. Elia Gigante is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Biselli, Maurizio, Massimo Iavarone, Matteo Renzulli, et al.. (2024). Impact of Sarcopenia on the Survival of Patients with Hepatocellular Carcinoma Treated with Sorafenib. Cancers. 16(6). 1080–1080. 2 indexed citations
2.
Gigante, Elia, Mohamed Bouattour, Hélène Regnault, et al.. (2023). Atezolizumab and bevacizumab for non-resectable or metastatic combined hepatocellular-cholangiocarcinoma: a multicentric retrospective study. Journal of Hepatology. 78. S577–S577. 1 indexed citations
3.
Gigante, Elia, Mohamed Bouattour, Josè Ursic‐Bedoya, et al.. (2023). Atezolizumab and bevacizumab for non‐resectable or metastatic combined hepatocellular‐cholangiocarcinoma: A multicentric retrospective study. United European Gastroenterology Journal. 12(4). 429–439. 4 indexed citations
4.
5.
Bissonnette, Julien, Elia Gigante, Larbi Boudaoud, et al.. (2022). Predicting bleeding after liver biopsy using comprehensive clinical and laboratory investigations: A prospective analysis of 302 procedures. Journal of Thrombosis and Haemostasis. 20(12). 2786–2796. 16 indexed citations
6.
Gigante, Elia, Jean‐Charles Nault, Olivier Sutter, et al.. (2022). Imaging and histological features of tumor biopsy sample predict aggressive intrasegmental recurrence of hepatocellular carcinoma after radiofrequency ablation. Scientific Reports. 12(1). 18712–18712. 2 indexed citations
7.
Roth, Gaël S., Stefano Caruso, Christian Sengel, et al.. (2022). Impact of sarcopenia on tumor response and survival outcomes in patients with hepatocellular carcinoma treated by trans-arterial (chemo)-embolization. World Journal of Gastroenterology. 28(36). 5324–5337. 11 indexed citations
8.
Blaise, Lorraine, Héléna Pereira, Valérie Vilgrain, et al.. (2021). Percutaneous ablation for locally advanced hepatocellular carcinoma with tumor portal invasion. Clinics and Research in Hepatology and Gastroenterology. 45(6). 101731–101731. 1 indexed citations
9.
Lequoy, Marie, Elia Gigante, Jean‐Pierre Couty, & Christèle Desbois‐Mouthon. (2020). Hepatocellular carcinoma in the context of non-alcoholic steatohepatitis (NASH): recent advances in the pathogenic mechanisms. Hormone Molecular Biology and Clinical Investigation. 41(1). 3 indexed citations
10.
Sartoris, Riccardo, Pierre‐Emmanuel Rautou, François Cauchy, et al.. (2020). Similar performance of liver stiffness measurement and liver surface nodularity for the detection of portal hypertension in patients with hepatocellular carcinoma. JHEP Reports. 2(5). 100147–100147. 13 indexed citations
11.
Gigante, Elia, Valérie Paradis, Maxime Ronot, et al.. (2020). New insights into the pathophysiology and clinical care of rare primary liver cancers. JHEP Reports. 3(1). 100174–100174. 32 indexed citations
12.
Gigante, Elia, Thibaut Léger, Miguel Albuquerque, et al.. (2018). Proteomic Landscape of Cholangiocarcinomas Reveals Three Different Subgroups According to Their Localization and the Aspect of Non‐Tumor Liver. PROTEOMICS - CLINICAL APPLICATIONS. 13(1). e1800128–e1800128. 14 indexed citations
13.
Antonelli, Giulio, Elia Gigante, Massimo Iavarone, et al.. (2018). Sarcopenia is associated with reduced survival in patients with advanced hepatocellular carcinoma undergoing sorafenib treatment. United European Gastroenterology Journal. 6(7). 1039–1048. 51 indexed citations
14.
Begini, Paola, Elia Gigante, Giulio Antonelli, et al.. (2016). Sarcopenia Predicts Reduced Survival in Patients with Hepatocellular Carcinoma at First Diagnosis. Annals of Hepatology. 16(1). 107–114. 59 indexed citations
15.
Gigante, Elia, Matteo Piciucchi, Emanuela Pilozzi, et al.. (2014). Liver biopsy: Analysis of results of two specialist teams. World Journal of Gastrointestinal Pathophysiology. 5(2). 114–114. 1 indexed citations
16.
Marignani, Massimo, Alfredo Marzano, Paola Begini, et al.. (2014). Perception of hepatitis B virus infection reactivation-related issues among specialists managing hematologic malignancies: result of an Italian survey. Leukemia & lymphoma. 55(11). 2564–2571. 6 indexed citations
17.
Begini, Paola, Maria Christina Cox, Stefano Angeletti, et al.. (2011). Effectiveness of entecavir in the management of acute hepatitis B developing in a patient with Hodgkin's lymphoma: A case report. Scandinavian Journal of Infectious Diseases. 43(9). 750–752. 3 indexed citations
18.
Marignani, Massimo, Manuela Mangone, Maria Christina Cox, et al.. (2010). HCV-positive status and hepatitis flares in patients with B-cell non-Hodgkin's lymphoma treated with rituximab-containing regimens. Digestive and Liver Disease. 43(2). 139–142. 29 indexed citations
19.
Marignani, Massimo, Michela Di Fonzo, Paola Begini, et al.. (2010). Use and Safety Perception of Herbal Remedies in Patients With Liver/Biliary Tract Disorders. Journal of Clinical Gastroenterology. 44(Supplement 1). S54–S57. 9 indexed citations
20.
Kisseleva, Tatiana, Elia Gigante, & David A. Brenner. (2010). Recent advances in liver stem cell therapy. Current Opinion in Gastroenterology. 26(4). 395–402. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshifumi Suga Breakdown of academic impact, for papers by Tomonari Okudaira Breakdown of academic impact, for papers by Takuya Kuwashiro Breakdown of academic impact, for papers by Ayumu Goto Breakdown of academic impact, for papers by Yifei Tan Breakdown of academic impact, for papers by Alessandro Giani Breakdown of academic impact, for papers by Soichi Iritani Breakdown of academic impact, for papers by Fatih Saygılı Breakdown of academic impact, for papers by Shirin Feshtali
Rankless by CCL
2026